Developments Fennec unveils PEDMARQSI in Germany for cisplatin-induced hearing loss in children Fennec Pharmaceuticals (NASDAQ:FENC; TSX:FRX) announced the commercial launch of PEDMARQSI sodium thiosulfate injection in Germany by Norgine Pharmaceuticals. The treatment is designed to prevent ototoxicity (permanent... February 7, 2025